Recent studies are shedding light on the potential of new anti-amyloid therapies to delay the onset of Alzheimer’s symptoms and reduce the risk of dementia. A small study has suggested that anti-amyloid therapy may keep symptoms at bay for certain patients. Additionally, researchers have discovered clues that hint at delaying Alzheimer’s, though further proof is needed to confirm these findings. Experimental drugs, including Gantenerumab and others, show promise in preventing or slowing the progression of Alzheimer’s disease, especially in those with specific genetic predispositions. However, concerns about research funding and bureaucratic slowdowns could impact the future of these promising treatments. As scientists continue to explore these avenues, families affected by Alzheimer’s are hopeful for breakthroughs that could significantly change the course of the disease.